| Wed, Sep 9, 2009 | | • | CLEVELAND BIOLABS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibi
EDGAR Online (Wed, Sep 9)
| | • | Cleveland BioLabs and Zhejiang Hisun Pharmaceutical Enter License Agreement for Protectan CBLB612 Hematopoietic Stem Cell Stimulator and Mobilizer in China
Marketwire (Wed, Sep 9)
| | Tue, Sep 8, 2009 | | • | Cleveland BioLabs to Present at NewsMakers in the Biotech Industry Conference
Marketwire (Tue, Sep 8)
| | Mon, Aug 31, 2009 | | • | Cleveland BioLabs to Present at Rodman & Renshaw 11th Annual Global Healthcare Conference
Marketwire (Mon, Aug 31)
| | Mon, Aug 17, 2009 | | • | Cleveland BioLabs Receives First U.S. Patent Allowance for Its Radiation Protection Drug Protectan CBLB502
Marketwire (Mon, Aug 17)
| | Thu, Aug 13, 2009 | | • | CLEVELAND BIOLABS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Thu, Aug 13)
| | Wed, Jul 1, 2009 | | • | Department of Defense Releases Further Funding to Cleveland BioLabs Under $8.8 Million Contract for Development Studies on Protectan CBLB502
Marketwire (Wed, Jul 1)
| | Fri, Jun 26, 2009 | | • | CLEVELAND BIOLABS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial
EDGAR Online (Fri, Jun 26)
| | Thu, Jun 25, 2009 | | • | Cleveland BioLabs Management Reviews Recent Highlights and Milestones at Annual Meeting
Marketwire (Thu, Jun 25)
| | Wed, Jun 3, 2009 | | • | Cleveland BioLabs Concludes Initial Phase I Safety and Tolerability Study for CBLB502
Marketwire (Wed, Jun 3)
| | Thu, May 28, 2009 | | • | Cleveland BioLabs Submits Response to Department of Defense Sources Sought Notice for Radiological and Nuclear Medical Countermeasures
Marketwire (Thu, May 28)
| | Thu, May 21, 2009 | | • | Cleveland BioLabs Signs Term Sheet for Joint Venture to Develop Curaxin Compounds for Cancer Applications
Marketwire (Thu, May 21)
| | Mon, May 18, 2009 | | • | Oncogene Publishes Cleveland BioLabs Paper on Mechanism of Action of Curaxins
Marketwire (Mon, May 18)
| | Fri, May 15, 2009 | | • | Cleveland BioLabs Formally Terminates Boston Stock Exchange Listing
Marketwire (Fri, May 15)
| | Thu, May 14, 2009 | | • | CLEVELAND BIOLABS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Thu, May 14)
| | Thu, Apr 9, 2009 | | • | CLEVELAND BIOLABS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Stand
EDGAR Online (Thu, Apr 9)
| | • | Cleveland BioLabs Updates Financial Condition Following Completion of Private Placement and Streamlining of Operations
Marketwire (Thu, Apr 9)
| | Mon, Mar 30, 2009 | | • | CLEVELAND BIOLABS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Sec
EDGAR Online (Mon, Mar 30)
| | • | Cleveland BioLabs Concludes Private Placement of Series D Preferred Stock and Common Stock Warrants
Marketwire (Mon, Mar 30)
| | Wed, Mar 25, 2009 | | • | Cleveland BioLabs to Host Investor Update Conference Call on March 31
Marketwire (Wed, Mar 25)
| | Mon, Mar 23, 2009 | | • | CLEVELAND BIOLABS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Sec
EDGAR Online (Mon, Mar 23)
| | • | Cleveland Biolabs Consummates Private Placement of Series D Preferred Stock and Common Stock Warrants
Marketwire (Mon, Mar 23)
| | Thu, Feb 19, 2009 | | • | Stem Cell Mad-ness
at Investopedia (Thu, Feb 19)
| | Tue, Feb 17, 2009 | | • | CLEVELAND BIOLABS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Sec
EDGAR Online (Tue, Feb 17)
| | • | Cleveland BioLabs Consummates Private Placement of Series D Preferred Stock and Common Stock Warrants
Marketwire (Tue, Feb 17)
|
Add CBLI News to My Yahoo!:
 
| |
|
0.51% Nasdaq 
Headlines
